• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. INDIGO SYSTEM ASPIRATION CATHETER 8; DXE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. INDIGO SYSTEM ASPIRATION CATHETER 8; DXE Back to Search Results
Catalog Number CAT8XTORQ115
Device Problem Collapse (1099)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/18/2019
Event Type  malfunction  
Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.This report is associated with mfr report number: 3005168196-2019-00738.
 
Event Description
The patient was undergoing a thrombectomy procedure in the femoral vein using an indigo system aspiration catheter 8 (cat8) and an indigo system separator 8 (sep8).During the procedure, the physician made multiple successful passes using the cat8 with the sep8 and a non-penumbra sheath.The physician then noticed under fluoroscopy that the distal tip of the cat8 was collapsing; therefore the cat8 was removed and was no longer used in the procedure.Additionally, it was reported that while the physician was advancing the sep8, resistance was met after the cat8 collapsed and became ovalized.The procedure was completed using another cat8 the same sep8 and the same sheath.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
Results: the indigo system aspiration catheter 8 (cat8) was ovalized approximately 10.0 cm, 19.0 cm, 51.5 cm, 58.0 cm, 93.0 ¿ 95.0 cm, 97.0 cm and from 113.0 ¿ 115.5 cm from the hub.Conclusions: evaluation of the returned cat8 confirmed an ovalization at the distal tip.It was reported that the device made approximately five passes into the target vessel prior to the ovalization being discovered.If the cat8 is advanced and retracted multiple times within the patient¿s anatomy, the device may fatigue.This may have contributed to the device becoming ovalized.If the cat8 is ovalized, resistance may be encountered while advancing a separator within the cat8 and also while manipulating the cat8 within the patient¿s anatomy.During functional testing, a demonstration sep8 was advanced in the returned cat8 and resistance was encountered at the distal ovalization.The sep8 was unable to advance further.The root cause of the ovalization could not be determined.Further evaluation revealed additional ovalizations along the length of the cat8.Some of these damages were likely incidental to the reported complaint and may have occurred during packaging for return to penumbra.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INDIGO SYSTEM ASPIRATION CATHETER 8
Type of Device
DXE
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key8525054
MDR Text Key142400939
Report Number3005168196-2019-00737
Device Sequence Number1
Product Code DXE
UDI-Device Identifier00814548016290
UDI-Public00814548016290
Combination Product (y/n)Y
PMA/PMN Number
K160533
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/01/2005,03/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/25/2021
Device Catalogue NumberCAT8XTORQ115
Device Lot NumberF87646
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/21/2019
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 03/18/2019
Initial Date FDA Received04/17/2019
Supplement Dates Manufacturer Received05/07/2019
Supplement Dates FDA Received05/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age52 YR
-
-